T he distribution of mRNAs and other RNA transcripts to specific subcellular locations has been widely studied via biochemical fractionation and/or hybridization and microscopy-based approaches [1] [2] [3] [4] . These studies have revealed that a substantial portion of mRNAs and other transcripts are differentially localized 2 , and that this localization is regulated and evolutionarily conserved 5 and is likely to have a role in shaping gene expression 6 . The combination of next-generation sequencing and biochemical fractionation allows for systems-level profiling of RNA localization but has thus far been limited to the analysis of a small number of compartments, including the nucleus, cytoplasm, mitochondria, and large structures such as neuronal dendrites or axons 1 . Recently, the more advanced tools available for high-throughput protein localization studies have been adapted for determination of RNA localization. One study used APEX2-mediated proximity biotinylation 7 followed by formaldehyde crosslinking to catalog mRNA and long noncoding RNAs (lncRNA) in the nucleus, mitochondria, and endoplasmic reticulum 8 . The engineered APEX2 peroxidase 7 can oxidize biotin-phenol in the presence of hydrogen peroxide to generate rapidly decaying biotin-phenoxyl radicals (t 1/2 < 1 ms) that can biotinylate proximal proteins at aromatic amino acid side chains. Through fusion to localization signals, APEX2 is targeted to specific cellular compartments and biotinylates the localized proteome, which can then be easily isolated by affinity chromatography and analyzed by mass spectrometry (MS). This approach has been successfully used to quantify the localized proteome of multiple subcellular compartments (reviewed in ref.
fusion protein is targeted to a cellular compartment of choice using a fused localization element (LE), and cellular RNAs are labeled with 4SU. b, Cells are incubated with biotin-phenol (BP) for 30 min, and then hydrogen peroxide is added to activate APEX2-mediated BP oxidation, followed by reaction quenching and 4SU-dependent protein-RNA crosslinking by UV. BP radicals are created locally and either covalently tag proximate proteins or decay. Compartment-specific RNPs and proteins are captured by streptavidin affinity chromatography. c, The eluate from b is split in three parts: the compartment proteome is analyzed by mass spectrometry (left) and the RNA is either treated by RNase and analyzed by small RNA cDNA library preparation of RBP-protected footprints, analogous to PAR-CLIP (middle), or analyzed by standard RNA-seq (right).
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Proximity-CLIP allows for the determination of the localized proteome by MS (as previously established 7 ) , which includes the RBPome that can be defined by comparison with published compendia of RBPs [12] [13] [14] ; the profiling of localized transcripts by RNAseq; and the identification and quantification of RBP-occupied cis-acting elements on transcripts, by sequencing of cDNA libraries from RNase-resistant footprints (Fig. 1c) . UV crosslinking of 4SU-labeled RNA to interacting proteins results in a characteristic T-to-C mutation in the corresponding cDNA libraries 10 . This feature allows for efficient computational removal of contaminating sequences derived from non-crosslinked fragments of abundant cellular RNAs, thus further increasing the specificity of Proximity-CLIP.
Proximity-CLIP identifies nuclear and cytoplasmic RNAs and proteins. As proof of principle, we first applied Proximity-CLIP to the cytoplasmic and nuclear compartments of human cells and generated stable HEK293 cells that inducibly expressed V5-tagged APEX2 constructs fused either to a nuclear export signal (NES) or to histone H2B 15 ( Fig. 2a) . As expected, immunofluorescence revealed protein biotinylation in the cytoplasm or the nucleus, respectively, following expression of APEX2-NES or H2B-APEX2 only after treatment with both biotin phenol (BP) and H 2 O 2 ( Fig. 2a) . Immunoblot analysis of lysates from 4SU-treated and UV-crosslinked cells also showed biotinylation of endogenous proteins in an APEX2-, BP-, and H 2 O 2 -dependent manner (Fig. 2b,c) . Biotinylated proteins, including RNPs, were then isolated by streptavidin affinity chromatography ( Supplementary Fig. 1a ). We profiled the nuclear and cytoplasmic proteome by tryptic digestion of the bead-immobilized material and analysis of the eluting peptides by MS (Supplementary Data 1) .
To test whether Proximity-CLIP identified proteins from the correct compartment, we performed functional enrichment analysis 16 of proteins biotinylated by H2B-APEX2 and APEX2-NES, respectively (Supplementary Data 1). As expected, proteins biotinylated by H2B-APEX2 were categorized as belonging to the 'nucleus' , 'nucleoplasm' , or transcription-related processes. Stringent filtering and comparison relative to cytoplasmic proteins resulted a list of 137 highly enriched nuclear proteins, of which 86 were RBPs that belonged to the mRNA processing or export machinery (Fig. 2d) , underscoring the centrality of RNA metabolism in nuclear processes. In contrast, although all enriched proteins biotinylated by APEX2-NES were known to be cytoplasmic, fewer annotation terms were significantly enriched, probably reflecting their functional diversity (Fig. 2e) . Finally, we verified that our proteome profiles correlated with a previously reported MS-based study of nuclear and cytoplasmic proteins 17 collected using other methods and cell lines ( Supplementary Fig. 1b-e) . In summary, Proximity-CLIP reliably identified compartmentalized proteins, including RBPs that were possibly crosslinked to RNA.
We then aimed to probe whether the capture of nuclear and cytoplasmic RNAs by Proximity-CLIP would recapitulate results obtained by biochemical fractionation of cytoplasm and nucleus. We eluted RNA with Proteinase K from streptavidin-immobilized and crosslinked RNPs biotinylated by APEX2-NES and H2B-APEX2, respectively, followed by standard RNA-seq library preparation and sequencing (Supplementary Data 2). Our RNA-seq results of both cytoplasmic and nuclear Proximity-CLIP correlated well with the RNA profiles from corresponding cell fractions (r s = 0.72 and r s = 0.80, respectively; Fig. 2f,g ), demonstrating the potential of Proximity-CLIP to complement or substitute for traditional biochemical fractionation.
Proximity-CLIP may provide global insights into protein occupancy on RNA. We treated crosslinked and streptavidin-immobilized nuclear and cytoplasmic RNPs with RNase, and sequenced isolated protein-protected RNA segments. We used the PARalyzer software 18 to determine RBP-binding sites or footprints that consisted of overlapping reads that contained T-to-C mutations that were diagnostic of the crosslinking event at higher frequencies than expected by chance (Supplementary Data 3) . In total, we identified 156,309 and 49,972 footprints in the nucleus and the cytoplasm, respectively (Fig. 2h) . Footprint annotation categories accurately reflected their subcellular origin: of the 41,203 RBP footprints on mRNA in the cytoplasm, 94% were found on mature mRNA, whereas of the 125,265 mRNA footprints in the nucleus, 43% resided in introns, similar to typical interactome profiles of nuclear or cytoplasmic RBPs 10 ( Fig. 2h) .
Proximity-CLIP reveals features of nuclear and cytoplasmic transcripts. Proximity-CLIP allowed us to test whether protein-coding transcripts interact with RBPs in a different manner both before nuclear export and in the cytoplasm. Metagene analysis of the coverage of nuclear and cytoplasmic RBP-protected footprints showed a decay in coverage near the transcription start site (TSS) that was more pronounced toward the 3′ end of the mRNA 3′ untranslated region (UTR) (Fig. 3a) and was probably a result of alternative TSS usage and cleavage and polyadenylation (CPA) sites 19, 20 . Consistent with a previous study analyzing protein occupancy on polyadenylated RNA 21 , we found that cytoplasmic mRNAs were predominantly bound by RBPs at their 3′ UTRs. However, this was not the case for nuclear mRNAs; the highest density of nuclear RBP footprints was found in their 5′ UTRs, rather than their 3′ UTRs, consistent with the dominant roles of the 5′ cap binding complex in mRNA nuclear export regulation [22] [23] [24] . This pattern was not observed previously in studies of RBP binding to total mRNA 21 , probably because of the lower relative abundance of nuclear versus cytoplasmic mRNA.
Proximity-CLIP detects mRNA processing intermediates. Next, we asked whether Proximity-CLIP captures nuclear RNA processing intermediates, such as intronic sequences, or immature premRNA 3′ ends. As expected, cytoplasmic mRNAs were depleted of intronic sequences, whereas nuclear RBP footprints exhibited even coverage of intronic sequences upstream and downstream of exons (Fig. 3b) . We found footprint coverage upstream of the annotated splicing branchpoints 25 in the nuclear Proximity-CLIP footprints, and a marked increase in footprints 20-50 nt downstream of the branchpoint, consistent with the known distances of the branchpoint to the downstream exon (Fig. 3c) . We also observed a slight dip in nuclear RBP footprint coverage around the branchpoint itself, which may be a result of RNA-RNA interactions with U2 snRNA 26 , precluding interaction and crosslinking to RBPs.
We next tested whether we could observe mRNA 3′ end formation that involves co-transcriptional endonucleolytic cleavage and subsequent polyadenylation at the CPA site. As expected, footprint coverage from the cytoplasmic Proximity-CLIP experiment was virtually undetectable after the annotated CPA sites, but we did detect nuclear RNA footprints downstream of the CPA site (Fig. 3d) . These sequences may represent the residual uncapped transcript emerging from PolII after CPA that needs to be degraded by XRN2 before PolII can disassociate from chromatin according to the torpedo model of transcription termination 27 . Consistently, a decay in coverage was apparent with distance from the CPA site; nevertheless, we still detected RBP-protected footprints several kilobases downstream of the CPA ( Supplementary Fig. 2a,b ), in agreement with recently reported widespread transcriptional readthrough 28, 29 . Finally, we focused on the TSS to determine whether Proximity-CLIP can recapitulate transcriptional features. By separating sense and antisense footprints around the TSS, we were able to observe bidirectional divergent transcription products in nuclear footprints, with only the sense footprints found in the cytoplasm ( Fig. 3e and Supplementary Fig. 2c ), reflecting a proposed bidirectional nature of most promoters and a rapid degradation of the antisense transcript [30] [31] [32] [33] . 
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We also identified some coverage of sense-oriented nuclear footprints directly upstream of the TSS (Supplementary Fig. 2c ), which may be promoter-associated small RNAs that were not exported 34 , or shortlived promoter upstream transcripts (PROMPTs) 35 .
Proximity-CLIP reveals features of abundant noncoding RNA classes. We asked whether Proximity-CLIP can provide insights into features of nuclear and cytoplasmic lncRNAs and crossed our data with a previously curated list of 61 lncRNAs
36
, of which about 30 were expressed in our system. lncRNAs may serve as microRNA (miRNA) precursors, and our nuclear dataset provided evidence of this phenomenon ( Supplementary Fig. 3 ). Several antisense lncRNAs initiated at their annotated TSS, but their transcript signal decayed gradually, which suggests that their expression might 
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be regulated during transcription elongation or that they are products of bidirectional transcription rather than stable transcripts of their own ( Supplementary Fig. 4 ). We detected expression of several lncRNAs in RNA-seq of total cell extracts, but Proximity-CLIP revealed that their transcription initiated upstream of the annotated TSS, in what appeared to be divergent transcription from neighboring genes ( Supplementary Fig. 5 ). Some transcripts annotated as lncRNAs appeared to be readthrough transcription products of protein-coding genes ( Supplementary Fig. 6 ). Finally, we also detected notable, yet anecdotal, expression patterns of lncRNAs: nuclear and cytoplasmic RAB30-AS1 exon 1 was differentially spliced ( Supplementary Fig. 7 ); a highly abundant uncharacterized small RNA, detectable only as an RBP footprint, was transcribed 7 kb upstream of TERC ( Supplementary Fig. 8 ); RBP footprints suggested that XIST was dominantly protein-bound at the 5′ ends of its first and last exons ( Supplementary Fig. 9 ); and although MALAT1 was expressed at high levels in HEK293 cells, the MALAT1-associated small cytoplasmic RNA (mascRNA) was completely undetectable ( Supplementary Fig. 10 ).
Next, we asked whether we could observe other noncoding RNAs processed in the nucleus and focused on primary miRNAs that were cleaved by the DROSHA-DGCR8 complex in the nucleus to generate ~80-100-nt-long precursor miRNA (pre-miRNA) hairpins and exported to the cytoplasm for further processing. As expected, our cytoplasmic RBP footprints exclusively covered pre-miRNA coordinates, particularly the sequences corresponding to the mature miRNAs, whereas nuclear footprints allowed for the detection of the short-lived primary miRNAs ( Fig. 3f and Supplementary Fig. 2d ).
To refine our analysis of small RNAs, we divided our footprints before cDNA library construction into two sizes, smaller and larger than 40 nt ( Supplementary Fig. 2e ), reasoning that longer footprints would stem only from unprocessed miRNA precursors, rather than the 21-23-nt-long mature species. For the longer footprints, cytoplasmic coverage dropped markedly, whereas nuclear footprint coverage did not change, indicating that we were indeed isolating miRNA precursors (Fig. 3g) . Separating long and short footprints may also prove to be useful for probing mature tRNA molecules and protein-bound tRNA fragments (tRFs) ( Supplementary Fig. 2f-j) . We captured full-length tRNAs 37 with long footprints (Supplementary Fig. 2f ) and were also able to visualize the reduction in coverage around the introns found in a number of tRNAs ( Supplementary Fig. 2g ). Analysis of the short footprints ( Supplementary Fig. 2h -j) revealed the potential to measure tRFs; consistent with previous reports from studies in HEK293 cells, cytoplasmic coverage at tRF-3 coordinates was higher than that at tRF-5 coordinates 38,39 ( Supplementary Fig. 2h ,j), and we also detected a signal at tRNA 3′ tail coordinates ( Supplementary Fig. 2i ) that might correspond to the previously reported tRF-1.
RBP footprints on mRNAs could provide insights into RNA regulatory elements occupied by RBPs in different compartments. Among the best characterized and reliably predictable cis-acting elements on mRNA are the miRNA-binding sites [40] [41] [42] occupied by the RNA-induced silencing complex (RISC). We extracted all of the predicted miRNA-binding sites of conserved miRNAs and calculated their RBP footprint coverage in the cytoplasm and the nucleus. Consistent with known RISC function in most cell types 41 , we found that predicted miRNA-binding sites were predominantly occupied in the cytoplasm, but not in the nucleus (Fig. 3h) . Furthermore, we asked whether we could detect differences in cytoplasmic miRNAbinding site occupancy of sites predicted to be regulated by miR-16, the miRNA with the highest expression in HEK293 cells, versus the targets of a non-expressed miRNA, miR-124. As expected, we only found RBP footprint coverage for miR-16 sites, which suggests that Proximity-CLIP indeed captured RNA regulatory elements (Fig. 3i) . Taken together, our results indicate that Proximity-CLIP can identify enriched proteins and RNAs, as well as RNA-protected footprints in our proof-of-principle compartments, the nucleus and the cytoplasm.
Proximity-CLIP identifies RNAs and proteins enriched at the cell-cell interface.
Given that nuclear and cytoplasmic RNPs can be easily fractionated via biochemical methods, we wanted to apply Proximity-CLIP to a compartment that is not accessible to other fractionation approaches. We chose to study the plasma membrane compartment at the cell-cell interface because it may be a site of localized translation, as well as of intercellular communication, which may involve RNA-dependent signaling and regulation 43 . Considering that exogenously expressed CNX43 is incorporated in cell-cell gap junctions 44 , we generated a stable HEK293 cell line expressing a CNX43-EGFP-APEX2 fusion protein that targeted APEX2 to cell-cell interfaces and enabled compartment-specific BP-and H 2 O 2 -dependent biotinylation of proteins ( Fig. 4a and Supplementary Fig. 11a ).
Standardization of CNX-43 Proximity-CLIP by a cytoplasmic Proximity-CLIP control resulted in a list of 612 cell-cell-interfaceenriched proteins, of which we used 229 to create a high-stringency list (Supplementary Data 4). Functional enrichment analysis of the relaxed and stringent protein lists resulted in similar trends, revealing annotations related to the cell-cell interface, such as 'cell-cell adherens junction' or 'cell junction' (Fig. 4b and Supplementary Fig. 11b ). To further validate our approach, we compared our data to a proteome related to another cell-cell interface marker, cadherin, that we defined from available data [45] [46] [47] obtained in studies with different cell lines and techniques. Although the localizations of cadherin and CNX43 only partially overlapped, the two proteomes shared significant similarity (Fig. 4c) : 40% of CNX43-proximate proteome was also found to be cadherin-related (P ≤ 2.2 × 10
−6
). We also profiled RBP-protected footprints at cell-cell interfaces and found that their distribution across mRNA annotation categories was indistinguishable from cytoplasmic footprints (Figs. 2h and 4d). We defined a set of 400 mRNAs enriched among cell-cellinterface transcripts, as well as a high-stringency list of 19 mRNAs that we found to be enriched in all datasets (Supplementary Data 5). mRNAs of cell-interface proteins were overrepresented, demonstrating the ability of Proximity-CLIP to isolate from the larger population of cellular transcripts a subset of mRNAs that potentially undergo local translation or regulation. The majority of enriched mRNA, however, encoded either proteins related to transcriptional regulation or transcription factors (Fig. 4e) . Consistently, among the top 19 localized RNAs, 10 encoded membrane-localized proteins, 5 encoded nuclear transcription factors, and 16 encoded regulatory proteins (Fig. 4f) . This result raises the possibility that, in addition to localized translation, this intricate membrane compartment also harbors mRNAs that are regulated in an external stimulation-dependent manner. Finally, to identify cis-acting elements that might be involved in RNA localization and regulation at cell-cell interfaces, we performed motif searches that revealed a significant enrichment of a CUG sequence element in the RBP-protected footprints from 3′ UTRs of the top 400 mRNAs at cell-cell interfaces ( Fig. 4g and Supplementary Fig. 11c ). Notably, a previous study reported the role of CUG-binding proteins in mRNA transport to the plasma membrane 48 , and we were able to exclusively detect one of those RBPs, CUGBP1, in the proteome localized at cell-cell interfaces (Supplementary Data 4).
Discussion
Precise control of RNA localization and translation allows cells to maintain proper protein distribution 2, 6 , and substantial effort has been invested to elucidate the subcellular localization of various transcripts. Our Proximity-CLIP approach provides a highthroughput method that allows for simultaneous profiling of localized RNA including short-lived species, and characterization of Articles NAtURE MEthOds enriched cis-acting elements, as well as candidate-interacting RBPs. The method is easy to use and can be adapted to query any subcellular compartment targeted by a localization signal across multiple cell types.
Compared with imaging-based technologies, Proximity-CLIP offers higher throughput, and by simultaneously probing for the proteome of the compartment of interest, Proximity-CLIP offers information on potential interaction partners and the local environment. Proximity-CLIP does not require chemical fixation or permeabilization of cells before analysis, which can increase experimental noise or perturb RNA localization 8 . RNA and protein localization have been studied in high throughput by fractionation-based approaches 1 . However, not all cellular compartments are accessible to fractionation, fractionation schemes may prove to be experimentally challenging, and incomplete separation can result in contaminations and/or false positive or negative identification of localized RNA. In addition, Proximity-CLIP does not require the preservation of cellular entities, which allows for the use of harsh extraction and purification conditions that result in rapid quenching of undesired cellular reactions, such as RNase activity, that may distort transcript identification and quantification. Nevertheless, in contrast with fractionation-based approaches that can be performed in unmodified cells and tissues, Proximity-CLIP requires the expression of APEX2 targeted to the compartment of interest and labeling with 4SU and BP, thus practically restricting its use to cultured cells.
A recent study reported an approach conceptually similar to the one we describe here, termed APEX-RIP 8 . In contrast with Proximity-CLIP, which uses UV crosslinking, APEX-RIP uses formaldehyde (FA) crosslinking of RNA and interacting proteins. However, FA is not a zero-distance crosslinker and can stabilize protein-protein interactions; thus, crosslinking conditions need to be carefully optimized to avoid long-distance crosslinking and detection of indirect interactions. Furthermore, our use of 4SU as a photoreactive nucleoside resulted in a diagnostic T-to-C mutation at the site of crosslinking 10 that allows for convenient bioinformatic removal of noise from co-purified RNAs that interact nonspecifically with the affinity chromatography matrix. Finally, FA crosslinking occurs after quenching of the APEX2 reaction, whereas Proximity-CLIP UV crosslinking occurs during quenching, thereby substantially reducing the time gap between protein biotinylation and protein-RNA linkage and minimizing diffusion and RNP rearrangements.
A distinctive feature of Proximity-CLIP is the sequencing of RBP-protected footprints that allows not only for profiling of localized RNAs, but also for the identification of protein-occupied cisacting elements on RNA. In contrast with previous global mapping of cis-acting elements 21 , our approach provides a snapshot of regulatory elements on RNA that are occupied in the examined compartments. A subset of our RBP footprints appeared to be derived from short-lived RNA species, probably by crosslinking to their processing enzymes, such as RNA polymerase or nuclear RNases; the detection and quantification of RNA intermediates might contribute to kinetic studies of RNA processing and turnover.
Application of Proximity-CLIP to multiple membranous compartments will help to answer the question of how proteins localize to concrete membrane niches 49 . Localized translation could enable the specific localization of peripheral, lipid-, and tail-anchored membrane proteins, and their mRNA would be guided by RBPs to these sites. In addition, localization of mRNAs with their encoded proteins enables tuning of their expression level according to confined needs to promote protein homeostasis of organelles and pathways 6, 50 . Notably, in addition to mRNAs that encode cell-cell interface proteins, we mostly found enriched mRNAs that encode gene regulatory proteins. Although hypothetical, the translation and stability of mRNAs that encode response factors to extracellular signals might benefit from being locally regulated at sites at which extracellular information is sensed, such as the plasma membrane, cell-cell interfaces, or sites along the endocytic pathway.
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Methods
A protocol for carrying out the Proximity-CLIP approach is available 51 .
Plasmids, cell lines, and media. pcDNA3 Connexin43-GFP-APEX2 1 and pCDNA3-APEX2-NES 52 were gifts from A. Ting (Addgene plasmids 49385 and 49386, respectively). All enzymatic manipulations for plasmid generation described below were performed using standard reaction conditions according to the enzyme manufacturer's instructions.
To construct pENTR221(APEX2-NES), the APEX2-NES sequence was amplified by PCR using pCDNA3-APEX2-NES 52 (Addgene 49386) as template and primers 5 and 6 (Supplementary Table 1) , and introduced by BP ligation into pDONR221 (Invitrogen) according to the manufacturer's instructions. To construct pDEST(frt)(N-ter_FLAGHA, C-ter AgeI site), pDEST(frt)(FLAGHA) 53 was amplified by PCR using primers 11 and 12, and self-ligated using T4 DNA ligase (NEB). To construct pEXP(FLAGHA-APEX2-NES), an LR reaction (Invitrogen) was performed to recombine the Apex2-NES sequence from pENTR221(APEX2-NES) into pDEST(frt)(N-ter_FLAGHA, C-ter AgeI site). Then, to construct pEXP(V5-APEX2-NES), pEXP(FLAGHA-APEX2-NES) was amplified by PCR using primers 9 and 10 and self-ligated. pEXP(V5-APEX2-NES) is available on Addgene (107596).
To construct pENTR221(APEX2), the APEX2 sequence was amplified by PCR using pCDNA3-APEX2-NES 52 (Addgene 49386) as template and primers 5 and 22, and introduced by BP ligation into pDONR221 (Invitrogen). To construct pENTR221(H2B-APEX2), an H2B megaprimer was amplified by PCR using pFC15A-H2B (a gift from Gordon Hager, NCI) as template and primers 24 and 25, and introduced by restriction-free (RF) cloning 54 into pENTR221(APEX2). To construct pDEST(frt)(N-ter_V5, C-ter AgeI site), pDEST(frt)(N-ter_FLAGHA, C-ter AgeI site) was amplified by PCR using primers 9 and 10, and self-ligated. Then, to construct pEXP(V5-H2B-APEX2), an LR reaction (Invitrogen) was performed to recombine the H2B-APEX sequence from pENTR221(H2B-APEX2) into pDEST(frt)(N-ter_V5, C-ter AgeI site). pEXP(V5-H2B-APEX2) was submitted to Addgene (107597).
Stable cell lines inducibly expressing V5_H2B_APEX2 or V5-APEX2-NES were prepared according to the manufacturer's instructions (Invitrogen) and as previously described: 55 Flp-In T-REx HEK293 cells (Invitrogen) were grown in standard medium (DMEM (Gibco, 11995-065), 10% FBS, 1:1,000 PenStrep (Gibco, 15140-122)), supplemented with 100 µ g/ml zeocin (frt site selection) + 15 µ g/ml blasticidin (tetR selection) ('pre-selection medium'). Cells were co-transfected with pEXP(V5-APEX2-NES) or pEXP(V5_H2B_APEX2) (Addgene plasmids 107596 and 107597, respectively) and pOG44 plasmid (Invitrogen) in the absence of PenStrep, and selected in standard growth medium supplemented with 100 µ g/ml hygromycin (pFRT insert) + 15 µ g/ml blasticidin ('post-selection medium'). To prepare a stable cell line expressing APEX2-EGFP-Connexin43, Flp-In T-REx HEK293 cells were transfected with pCDNA3-Connexin43-GFP-APEX2 (Addgene plasmid 49385), and selected by standard medium supplemented with 350 µ g/ml G418.
Proximity-CLIP.
In plating cells for Proximity-CLIP, we aimed to achieve high, yet not full, confluence on the day of labeling (80-90%), which for our scheme requires at least 20 × 10 6 cells on the day of cell splitting to suffice for preparative and control samples, as well as for immunofluorescence (IF). For confocal microscopy, cells were seeded into a 24-well plate over PLL-coated (Sigma, P8920) glass coverslips at a density of 2.5 × 10 5 cells per well. For western blotting analyses, 2.5 × 10 6 cells were seeded per sample into a 6-cm plate. For preparative Proximity-CLIP, 15 × 10 6 cells were seeded per sample in 15-cm dishes. 16 h after seeding, 2 μ g/ml doxycycline (DOX) was added to negative-control cells (the parental HEK293 T-Rex cells) and to cell lines inducibly expressing V5-H2B-APEX2 and V5-APEX2-NES. 4-thiouridine (4SU; Sigma; 100 μ M final concentration from a 500 mM stock solution in water) was added directly to the growth medium in all 6-cm and 15-cm plates. Sixteen hours after DOX induction and 4SU labeling, 500 μ M biotin-phenol (BP; iris-biotech, ls-3500.1000; using 500 mM BP in a DMSO stock aliquot stored at -80 °C) was added to the growth medium, and culture plates were returned to the incubator for 30 min. During incubation with BP, fresh quenching solution was prepared by combining sodium ascorbate (VWR; 10 mM; 1 M stock solution freshly dissolved in ddH 2 O), Trolox (Sigma, 238813; 5 mM; freshly dissolved 500 mM stock solution in DMSO), and sodium azide (10 mM; 1 M stock solution in water can be stored at -20 °C or below for a year) in pre-chilled PBS (Gibco, 10010-023).
After 30 min in the presence of BP, a freshly made stock of 100 mM H 2 O 2 (Sigma) in PBS was added to cell culture medium to a final concentration of 1 mM for 60 s; medium was quickly discarded and cells were quickly (but gently, to minimize cell loss) washed three times in large volumes (at least twice the medium volume per wash) of quencher solution. Then, 750 µ l of quenching solution was added to stop the biotinylation reaction in plates and 500 µ l was added to 24 wells.
Cells growing in 6-or 15-cm plates were subjected to 312-nm UV crosslinking, without plates cap, at 0.15 J/cm 2 , using a Spectrolinker XL-1500 (Spectronics). Crosslinked cells were collected by gentle scraping and pelleted by centrifugation for 5 min at 300g and 4 °C. The supernatant was discarded, and cells were snap frozen in liquid nitrogen.
Fluorescence microscopy. Quenched cells in 24-well plates were fixed with 4% PFA in PBS for 20 min. Fixed cells were washed three times with PBS, and further fixed and permeabilized by -20 °C cold methanol and further incubation for 20 min at -20 °C. Then, cells were blocked with 5% BSA (wt/vol) in PBS (blocking solution) for 60 min. Labeling with primary mouse anti-V5 antibody (R960-25, Thermo Scientific) was performed in a humid chamber overnight at 4 °C (1:400 dilution in blocking solution), followed by washing three times for 5 min with PBS. Then, fixed cells were incubated with Alexa-Fluor-488-coupled Goatα Mouse (Thermo, A11001) and Alexa-Fluor-647-coupled Neutroavidin (self-made, as described in ref. 7 ) for 1 h at room temperature (1:600 and 1:300 dilutions, respectively). Finally, fixed cells were washed three times for 5 min with PBS and mounted over 9-µ l Vectashield with DAPI (VECTOR, H-1200).
Cell fractionation. Fractionation was performed as described previously 56 , with a few modifications. Briefly, 10 5 cells were pelleted in PBS at 250g and resuspended in 380 µ l of HLB (10 mM Tris, pH 7.5, 50 mM NaCl, 3 mM MgCl 2 , 0.1% NP-40, and 10% glycerol). After a 2-min incubation, cells were centrifuged at 400g and the supernatant (cytoplasm) was obtained. The pellet was washed three times (resuspended in 1 ml of HLB and centrifuged at 200g) with HLB buffer. RNA was extracted from the nuclei using TRIzol reagent.
Cell extraction and streptavidin pulldown for western blotting controls.
Cell pellets originating from 6-cm plates were resuspended in 300 µ l of RIPA buffer (50 mM Tris, 150 mM NaCl, 0.1% (wt/vol) SDS, 0.5% (wt/vol) sodium deoxycholate, and 1% (vol/vol) Triton X-100, pH 7.5), supplemented with 1× protease inhibitor cocktail without EDTA (Roche, 04693159001), 1 mM PMSF, and fresh quenching solution (10 mM sodium azide, 10 mM sodium ascorbate, and 5 mM Trolox; see section "Proximity-CLIP" above for preparation). The cell suspension was incubated on ice for 2 min, and extracts were clarified by centrifugation at 15,000g for 10 min at 4 °C. Cell extracts were kept on ice throughout the procedure. Protein concentration in cell extracts was quantified using the Pierce 660-nm assay (Pierce, 22660) (typical protein concentration was around 1.2 μ g/µ l).
150 µ l of RIPA buffer was added to 150 µ g of cell extract for each sample to increase volume and incubated with 15 µ l of streptavidin magnetic beads prewashed in RIPA buffer at 4 °C overnight on a rotator. Note: this step can also be done for 1 h at room temperature. Remaining extract was saved for gel and western blotting analysis. Notes: when handling the streptavidin magnetic beads, either 1-ml or cut 200-µ l pipette tips were used. Beads were collected using a magnetic rack, and the supernatant (flow-through, FT) was saved on ice for subsequent analysis. Beads were washed using a series of ice-cold buffers (1 ml for each wash) to remove nonspecific binders, as follows: 2× with RIPA buffer, 1× with 1 M KCl, 1× with 0.1 M Na 2 CO 3 , 1× with 2 M urea in 10 mM Tris-HCl, pH 8.0 (freshly prepared), and 2× again with RIPA buffer.
We eluted biotinylated proteins for western blotting analysis by heating each sample in 60 µ l of 3× protein loading buffer (for 6× , take 10.5 ml of ddH 2 O, 10.5 ml of 1 M Tris, pH 6.8, 10.8 ml of glycerol, 3 g of SDS, 2.79 g of DTT, and 3.6 mg of bromophenol blue) supplemented with 2 mM biotin and an additional 20 mM DTT for 10 min (97 °C, with vortexing). Samples were then cooled to room temperature, briefly centrifuged, and placed on a magnetic rack for collection of the eluate. For western blotting analysis, 10 µ l of eluate was loaded per lane of a 4-20% (wt/vol) gradient SDS polyacrylamide gel.
Cell extracts and FT were supplemented with 1× protein loading buffer, heated to 97 °C, chilled, and briefly centrifuged for collection of condensate. Samples were loaded at equal protein quantities (accounting for FT volume increase due to the addition of RIPA buffer for incubation with streptavidin beads) and run through a 4-20% (wt/vol) gradient SDS polyacrylamide gel.
Preparative cell extraction and streptavidin pulldown. Cell pellets originating from 15-cm plates were resuspended in 800 µ l of RIPA buffer supplemented with 1× protease inhibitor cocktail without EDTA, 1 mM PMSF, and fresh quenchers (10 mM sodium azide, 10 mM sodium ascorbate, and 5 mM Trolox, preparation; see section "Proximity-CLIP"). Resuspended cells were incubated on ice for 2 min, and extracts were cleared by centrifugation at 15,000g for 10 min at 4 °C. Cell extracts were kept on ice throughout the procedure. Protein concentration in cell extracts was quantified using the Pierce 660-nm assay (Pierce, 22660) (typical protein concentration was around 3 μ g/µ l).
30 µ l of the cell extracts was saved for total RNA isolation and RNA-seq (see below), and another 80 µ l was saved for protein, gel, and western blotting analyses. For each sample, 1.5 mg of protein extract (~500 µ l) was incubated with 60 µ l of prewashed streptavidin magnetic beads with rotation at room temperature for 1 h. Beads were pelleted with a magnetic rack and FT was collected and saved for subsequent analysis. Beads were then washed using a series of buffers as described above in the section "Cell extraction and streptavidin pulldown for western blotting controls". At the final wash step, the beads were divided into three aliquots: (1) 300 µ l for mass spectrometry-liquid removed and beads kept on ice; (2) 200 µ l for bound-RNA-seq (no RNase treatment-liquid was removed and beads were frozen at -80 °C); and (3) 500 µ l for RNase T1 treatment (continued immediately).
RBP footprinting and radiolabeling of
, 1% NP-40), supplemented with RNase T1 (Thermo, EN0541) to a final concentration of 1 U/µ l, and incubated for 15 min at 22 °C. Reactions were chilled on ice for 5 min, and beads were washed twice with RNase T1 buffer and once with dephosphorylation buffer (NEB cutsmart buffer 1× ). Beads were then resuspended in 60 µ l of dephosphorylation mix (per 300 µ l of mix, take 30 µ l of 10× cutSmart, 255 µ l of ddH 2 O, and 15 µ l of CIP, 10 U/µ l) and incubated for 10 min at 37 °C with shaking. Note: adjust the shaking speed on the thermomixers so the beads do not settle. Beads were then washed twice with 1 ml of dephosphorylation buffer and twice with 1 ml of PNK buffer without DTT (50 mM Tris, pH 7.5, 50 mM NaCl, and 10 mM MgCl 2 ). Then, beads were resuspended in 60 µ l of radioactive reaction mix (per 300 µ l of mix take 245 µ l of ddH 2 O, 30 µ l of 10× PNK buffer (NEB), 30 µ l of PNK (NEB) to 1 U/µ l, 5 µ l *ATP (0.5 μ Ci [γ -32 P]ATP]) and incubated for 30 min at 37 °C with shaking. Note: adjust the shaking speed on the thermomixers so the beads do not settle. Then, non-radioactive ATP was added to a final concentration of 100 µ M and incubation continued for an additional 5 min.
Beads were then washed five times with 1 ml of PNK buffer without DTT (exposure to > 1 mM DTT for a prolonged time may damage magnetic beads, and it should be used only in the reaction buffer). Note: we saved 50 µ l of the radioactive waste, which is collected after the first bead wash, to mark the urea-PAGE gels, as described later in the text. Radioactivity on the beads was estimated with a Geiger counter after completion of washing, and beads were stored at -20 °C, while the samples for mass spectrometry analysis were processed.
Protein sample preparation and mass spectrometry. Beads kept on ice (see above in section "Preparative cell extraction and streptavidin pulldown") were resuspended in 30 µ l of 25 mM ammonium bicarbonate and 20 mM DTT (Thermo, 20291) and incubated at increasing temperatures for 1 h under constant agitation: 25 °C (30 min), 37 °C (20 min), and 56 °C (10 min). Then, 6 µ l of 200 mM iodoacetamide (Thermo, 90034) (in 25 mM ammonium bicarbonate) was added and tubes were further shaken for 1 h at 25 °C. Beads were collected on a magnet and washed three times in 200 µ l of 1 mM DTT in 25 mM ammonium bicarbonate to quench the remaining iodoacetamide and to ensure depletion of detergents from previous steps. Freshly dissolved trypsin (Promega, V5111) was dissolved at 20 μ g/ml in 25 mM ammonium bicarbonate. Then, beads were resuspended in 98 µ l of 25 mM ammonium bicarbonate, supplemented with 2 µ l of trypsin (40 ng). Tubes were shaken overnight at 37 °C in a mixer with a lid to avoid condensation. Finally, beads were pelleted and the eluate was collected in fresh tubes for further processing by the proteomics facility. As a control, the procedure above was also carried out on empty beads.
Mass spectrometry was performed on an Orbitrap Fusion coupled with an Ultimate 3000 nLC (Thermo). Peptides were separated on an EASY-Spray C 18 column (Thermo; 75 μ m × 25 cm inner diameter, 2-μ m particle size and 100-Å pore size). Separation was achieved by 5-35% linear gradient of acetonitrile + 0.1% formic acid over 120 min. An electrospray voltage of 2.1 kV was applied to the eluent via the EASY-Spray column electrode. The Orbitrap Fusion was operated in positive ion data-dependent mode. Full-scan mass spectrometry 52 was performed in the Orbitrap with a normal precursor mass range of 350-1,500 m/z at a resolution of 120,000. The automatic gain control (AGC) target and maximum accumulation time settings were set to 4 × 10 5 and 50 ms, respectively. MS 2 was triggered by selection of the most intense precursor ions above an intensity threshold of 5 × 10 3 for collision-induced dissociation (CID)-MS 2 fragmentation with AGC target and maximum accumulation time settings of 5 × 10 2 and 250 ms, respectively. Mass filtering was performed by the quadrupole with a 1.6 m/z transmission window, followed by CID fragmentation in the ion trap (rapid mode) and a normalized collision energy (NCE) of 35%. To improve the spectral acquisition rate, parallelizable time was activated. The number of MS 2 spectra acquired between full scans was restricted to a duty cycle of 3 s.
Elution of RNA from beads. Bead-immobilized RNPs (RNase treated or not, stored at -80 °C and -20 °C, respectively) were proteolytically digested with proteinase K to elute the RNA. Beads were defrosted and digestion was performed in three subsequent steps, each time adding to the existing volume for a final volume of 500 µ l: (1) addition of 1.2 mg/ml proteinase K in 200 µ l of 1× proteinase K buffer (50 mM Tris, pH 7.5, 75 mM NaCl, 6.25 mM EDTA, 1% SDS), followed by incubation at 50 °C in a heat block under vigorous shaking for 30 min (for nine samples, weigh 2.16 mg of proteinase K and resuspend in 1.8 ml of buffer), (2) addition of 0.75 mg/ml proteinase K in 150 µ l of 1× proteinase K buffer, followed by incubation at 50 °C for 30 min (for nine samples, weigh 1.01 mg and resuspend in 1.35 ml of buffer), and (3) addition of 0.75 mg/ml proteinase K in 150 µ l of 1× proteinase K buffer, followed by incubation at 50 °C. At the end of the reaction, tubes were briefly centrifuged, beads were collected on a magnetic rack, and the RNA-containing supernatant was transferred to a new 1.5-ml microcentrifuge tube, combined with 30 µ l of 5 M NaCl and 300 µ l of acidic phenol-chloroform (pH 4.5) and mixed by vortexing. After a 10-min incubation at room temperature, tubes were centrifuged at 12,000g for 2 min and the aqueous phase was transferred to a new 1.5-ml microcentrifuge tube, combined with 300 µ l of chloroform, vortexed and centrifuged at 12,000g for 2 min. The aqueous phase was then transferred to a new 1.5-ml microcentrifuge tube, and RNA was precipitated by addition of 1 µ l of GlycoBlue (Thermo, AM9516) (10 mg/ml), mixing, and addition of 3 volumes of ethanol, incubation at -20 °C for at least 1 h, and centrifugation at > 12,000g and 4 °C for 20 min. After removal of all ethanol traces, pellets were air-dried for 5 min at room temperature and dissolved in 20 µ l of DEPC-treated ddH 2 O.
RNA extraction from total cell extracts. RNA from the 30 µ l samples of total extracts (see section "Preparative cell extraction and streptavidin pulldown") was extracted by consecutive and immediate addition of 370 µ l of DEPC-treated ddH 2 O (to increase the volume of aqueous phase) and 400 µ l of biophenol (Sigma, P3803), vortexing, incubation for 15 min at room temperature, and centrifugation for 10 min at maximum speed. The top 200 µ l of aqueous phase was transferred to a new tube, to which the same volume of ddH 2 O-saturated chloroform was added, vortexed, and centrifuged for 8 min at maximum speed. The top 100 µ l of aqueous phase was transferred to a new tube, combined with 7 µ l of 3 M sodium acetate, pH 5.3, and 400 µ l of cold ethanol, vortexed, and incubated at -80 °C for at least 3 h. The RNA precipitate was pelleted by centrifugation at 4 °C at > 12,000g for 15 min; pellets were washed twice with 500 µ l of 75% ethanol, air-dried for 5 min, and resuspended in 20 µ l of DEPC-treated ddH 2 O.
RNA-seq library preparation. RNA-seq libraries were prepared with the NEBnext RNA sequencing kit (E7530) according to the manufacturer's instructions with the following parameters: (1) rRNA depletion was performed only on total RNA samples using the NEB rRNA depletion kit (E6310) and (2) RNA fragmentation was performed for 10 min. The barcodes used are listed in Supplementary Table 1; all FASTQ files were uploaded to GEO after demultiplexing.
sRNA library preparation. Small RNA cDNA libraries were prepared as previously described 57,58: To determine the size of RBP-protected RNA fragments, samples were loaded and separated by denaturing polyacrylamide electrophoresis (National Diagnostics, EC830/835/840 in 1× TBE), next to RNA size markers (Supplementary Table 1 ). RNA footprints were visualized by autoradiography, and bands representing estimated lengths of 20-40 and 41-70 nt were excised and extracted from the gel as follows: (1) 57 for preparation instructions), and 2 µ l of 10 μ M adenylated 3′ adaptor 57 (adaptor sequence in Supplementary Table 1) , followed by incubation for 1 min at 90 °C. The reaction was chilled on ice for 1 min; 1 µ l of T4 Rnl2(1-249)K227Q (1 μ g/µ l) (NEB) was added and the reaction was incubated overnight on ice.
To separate the ligated product from unligated footprints and excess adenylated adaptor, samples were combined with 20 µ l of denaturing PAA gel loading solution, incubated for 1 min at 90 °C, and separated on a 15% denaturing PAA gel in 1× TBE. RNA was visualized by autoradiography and ligated footprints with inserts comparable to the 19-and 35-nt marker (for 20-40-b footprints) and above (for 40-70-b footprints) were excised ( Supplementary Fig. 3e ). Nucleic acids were extracted from gels as described above and resuspended in 9 µ l of DEPC-treated ddH 2 O.
Adaptor ligation at the 5′ end was performed by addition of 1 µ l of 100 μ M 5′ adaptor 57 (Supplementary Table 1 ), 2 µ l of 10× RNA ligase buffer with ATP (Thermo), and 6 µ l of 50% DMSO, denaturing for 1 min at 90 °C followed by chilling of tubes on ice for 1 min, addition of 2 µ l of Rnl1 (1 mg/ml, Thermo), and a 1-h incubation at 37 °C.
To separate the ligated product from unligated footprints and excess adenylated adaptor, samples were combined with 20 µ l of denaturing PAA gel loading solution, incubated for 1 min at 90 °C, and loaded and separated on a 12% denaturing PAA gel. RNA was visualized by autoradiography and ligated footprints were excised as above. Nucleic acids were extracted from gels as described above and resuspended in 4.6 µ l of DEPC-treated ddH 2 O.
Ligated RNA footprints were denatured by incubation at 90 °C for 1 min, cooled to 50 °C in a thermocycler, and reverse-transcribed by addition of 1.5 µ l of 100 mM DTT, 3 µ l of 5× first-strand buffer (Invitrogen), 4.2 µ l of 2 mM dNTPs, 1 µ l of 100 μ M reverse PCR primer (3′ barcoded primer; Supplementary Table 1) , and 0.7 µ l of Superscript III reverse transcriptase (Thermo), followed by incubation for 1 h at 50 °C. The cDNA product was diluted by addition of 85 µ l of DEPC-treated ddH 2 O to a volume of 100 µ l, and 6 µ l of it was used as template for a diagnostic PCR as follows.
A 60-µ l diagnostic PCR reaction was set up by combining 38.6 µ l of ddH 2 O, 6 µ l of 10× Platinum Taq buffer without magnesium (Invitrogen, 10966018), 1.8 µ l of 50 mM MgCl 2 , 6 µ l of 2 mM dNTPs, 0.6 µ l of 100 μ M 3′ barcoded primer, 0.6 µ l of 100 μ M 5′ primer (Supplementary Table 1 The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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